Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ITGR
Upturn stock ratingUpturn stock rating

Integer Holdings Corp (ITGR)

Upturn stock ratingUpturn stock rating
$122.97
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/30/2025: ITGR (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

10 Analysts rated it

Well-followed company, solid analyst reports, reliable data for confident investing.

1 Year Target Price $148.75

1 Year Target Price $148.75

Analysts Price Target For last 52 week
$148.75Target price
Low$104.93
Current$122.97
high$146.36

Analysis of Past Performance

Type Stock
Historic Profit 23.8%
Avg. Invested days 76
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 4.0
Stock Returns Performance Upturn Returns Performance 3.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/30/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 4.28B USD
Price to earnings Ratio 57.27
1Y Target Price 148.75
Price to earnings Ratio 57.27
1Y Target Price 148.75
Volume (30-day avg) 10
Beta 0.98
52 Weeks Range 104.93 - 146.36
Updated Date 06/30/2025
52 Weeks Range 104.93 - 146.36
Updated Date 06/30/2025
Dividends yield (FY) -
Basic EPS (TTM) 2.14

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 4.4%
Operating Margin (TTM) 12.67%

Management Effectiveness

Return on Assets (TTM) 4.51%
Return on Equity (TTM) 4.98%

Valuation

Trailing PE 57.27
Forward PE 21.93
Enterprise Value 5599260907
Price to Sales(TTM) 2.45
Enterprise Value 5599260907
Price to Sales(TTM) 2.45
Enterprise Value to Revenue 3.21
Enterprise Value to EBITDA 20.24
Shares Outstanding 34892000
Shares Floating 34498413
Shares Outstanding 34892000
Shares Floating 34498413
Percent Insiders 0.89
Percent Institutions 116.4

Analyst Ratings

Rating 4
Target Price 148.75
Buy 2
Strong Buy 7
Buy 2
Strong Buy 7
Hold 1
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Integer Holdings Corp

stock logo

Company Overview

overview logo History and Background

Integer Holdings Corp. (formerly Greatbatch) was founded in 1970. Initially focused on battery technology for cardiac pacemakers, it has evolved into a major medical device outsource manufacturer, providing design, development, and manufacturing services for a wide range of medical devices and components.

business area logo Core Business Areas

  • Medical: Manufactures and develops medical devices and components, including pacing, neuromodulation, vascular, cardiac rhythm management, and orthopedic applications.
  • Advanced Surgical & Specialty: Focuses on advanced surgical and specialty medical applications.

leadership logo Leadership and Structure

The leadership team includes Payman Khales, President & CEO. The company has a typical corporate structure with various departments including operations, finance, sales, and marketing.

Top Products and Market Share

overview logo Key Offerings

  • Cardiac Rhythm Management (CRM) Devices & Components: Integer provides components and finished devices for cardiac rhythm management, competing with Medtronic (MDT), Abbott (ABT), and Boston Scientific (BSX). Estimated Market Share Data can vary due to being components and finished devices, difficult to accurately define.
  • Neuromodulation Devices & Components: Integer manufactures components used in neuromodulation therapies for pain management and neurological disorders, competing with Medtronic (MDT), Boston Scientific (BSX), and Abbott (ABT). Estimated Market Share Data can vary due to being components and finished devices, difficult to accurately define.
  • Vascular Devices & Components: Integer develops components for vascular medical devices and is competing against Medtronic (MDT) and Boston Scientific (BSX). Estimated Market Share Data can vary due to being components and finished devices, difficult to accurately define.

Market Dynamics

industry overview logo Industry Overview

The medical device industry is experiencing steady growth driven by an aging population, increasing prevalence of chronic diseases, and technological advancements. Stringent regulatory requirements and competitive pricing pressures are significant factors.

Positioning

Integer is positioned as a leading medical device outsource manufacturer (MDOM) and component supplier. Its competitive advantage lies in its technical expertise, manufacturing capabilities, and long-standing relationships with major medical device companies.

Total Addressable Market (TAM)

The total addressable market for medical device outsourcing is estimated to be in the tens of billions of dollars annually. Integer is positioned well to capture a significant portion of this TAM through its focus on high-growth medical device segments.

Upturn SWOT Analysis

Strengths

  • Strong technical expertise in medical device manufacturing
  • Established relationships with leading medical device companies
  • Diverse product portfolio
  • Global manufacturing footprint
  • Strong IP position

Weaknesses

  • Customer concentration
  • Dependence on key suppliers
  • Vulnerable to changing regulatory landscape
  • Limited brand recognition with end consumers
  • Slower growth compared to some competitors

Opportunities

  • Expanding into new geographic markets
  • Developing new technologies and products
  • Acquiring complementary businesses
  • Benefiting from increasing demand for outsourced medical device manufacturing
  • Penetrating high-growth medical device segments such as robotics

Threats

  • Intense competition from other medical device manufacturers
  • Pricing pressures from customers
  • Changes in regulatory requirements
  • Economic downturn
  • Product liability risks

Competitors and Market Share

competitor logo Key Competitors

  • Medtronic (MDT)
  • Boston Scientific (BSX)
  • Abbott (ABT)

Competitive Landscape

Integer competes with major medical device OEMs as well as other contract manufacturers. Integer differentiates itself through its technical expertise, focus on complex devices, and vertically integrated manufacturing capabilities.

Major Acquisitions

Lake Region Medical

  • Year: 2015
  • Acquisition Price (USD millions): 1725
  • Strategic Rationale: Expanded product portfolio and increased scale in the medical device market.

Oscor

  • Year: 2016
  • Acquisition Price (USD millions): 193
  • Strategic Rationale: Expanded offerings of specialized delivery systems and lead technologies.

Growth Trajectory and Initiatives

Historical Growth: Historical growth data requires specific financial data. Consult Integer Holdings Corp's SEC filings.

Future Projections: Future growth projections require analyst estimates. Consult financial data providers for this information.

Recent Initiatives: Recent initiatives involve strategic acquisitions, facility expansion, and new product development to accelerate growth and strengthen market position.

Summary

Integer Holdings Corp. is a significant player in the medical device outsourcing market, leveraged to the medical device industry but not as large as its peers. Their core strength lies in complex medical devices and contract manufacturing. Key challenges include competition from larger players and vulnerability to industry regulations. Recent acquisitions and initiatives show a focus on strategic growth.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Integer Holdings Corp. Investor Relations
  • SEC Filings
  • Market Reports
  • Financial News Outlets

Disclaimers:

The information provided is for informational purposes only and should not be considered financial advice. Market share data is approximate and may vary depending on the source. Always consult with a qualified financial advisor before making investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Integer Holdings Corp

Exchange NYSE
Headquaters Plano, TX, United States
IPO Launch date 2000-09-29
President, CEO & Director Mr. Joseph W. Dziedzic
Sector Healthcare
Industry Medical Devices
Full time employees 11000
Full time employees 11000

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Puerto Rico, Costa Rica, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. The company was founded in 1970 and is headquartered in Plano, Texas.